Identification of genomic expression differences between right-sided and left-sided colon cancer based on bioinformatics analysis

References

• SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDFedewaSAColorectal cancer statistics, 2017CA Cancer J Clin201767317719328248415
   PubMed Web of Science ®Google Scholar
• LeeMSMenterDGKopetzSRight versus left colon cancer biology: integrating the consensus molecular subtypesJ Natl Compr Canc Netw201715341141928275039
   PubMed Web of Science ®Google Scholar
• LoupakisFYangDYauLPrimary tumor location as a prognostic factor in metastatic colorectal cancerJ Natl Cancer Inst20151073dju42725713148
   PubMedGoogle Scholar
• KuramochiHNakamuraANakajimaGPTEN mRNA expression is less pronounced in left- than right-sided colon cancer: a retrospective observational studyBMC Cancer20161636627296289
   PubMed Web of Science ®Google Scholar
• BauerKMHummonABBuechlerSRight-side and left-side colon cancer follow different pathways to relapseMol Carcinog201251541142121656576
   PubMed Web of Science ®Google Scholar
• JorissenRNGibbsPChristieMMetastasis-associated gene expression changes predict poor outcomes in patients with dukes stage B and C colorectal cancerClin Cancer Res200915247642765119996206
   PubMed Web of Science ®Google Scholar
• Gene Ontology ConsortiumThe gene ontology (GO) project in 2006Nucleic Acids Res200634Database IssueD322D32616381878
   PubMed Web of Science ®Google Scholar
• KanehisaMGotoSKEGG: kyoto encyclopedia of genes and genomesNucleic Acids Res2000281273010592173
   PubMed Web of Science ®Google Scholar
• Huang daWShermanBTLempickiRASystematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNat Protoc200941445719131956
   PubMed Web of Science ®Google Scholar
• SzklarczykDMorrisJHCookHThe STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessibleNucleic Acids Res201745D1D362D36827924014
   PubMed Web of Science ®Google Scholar
• ShannonPMarkielAOzierOCytoscape: a software environment for integrated models of biomolecular interaction networksGenome Res200313112498250414597658
   PubMed Web of Science ®Google Scholar
• LewisRMutation and location important in cancer treatmentLancet Oncol20151613e482
   Web of Science ®Google Scholar
• WeissJMPfauPRO’ConnorESMortality by stage for right-versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results – Medicare dataJ Clin Oncol201129334401440921969498
   PubMed Web of Science ®Google Scholar
• PetrelliFTomaselloGBorgonovoKPrognostic survival associated with left-sided vs right-sided colon cancer: a systematic review and meta-analysisJAMA Oncol Epub20161027
   PubMed Web of Science ®Google Scholar
• WangSCPCNA: a silent housekeeper or a potential therapeutic target?Trends Pharmacol Sci201435417818624655521
   PubMed Web of Science ®Google Scholar
• MoldovanGLPfanderBJentschSPCNA, the maestro of the replication forkCell2007129466567917512402
   PubMed Web of Science ®Google Scholar
• LiuYZhangXHanCTP53 loss creates therapeutic vulnerability in colorectal cancerNature2015520754969770125901683
   PubMed Web of Science ®Google Scholar
• HuBZhangYJiaLBinding of the pathogen receptor HSP90AA1 to avibirnavirus VP2 induces autophagy by inactivating the AKT-MTOR pathwayAutophagy201511350351525714412
   PubMed Web of Science ®Google Scholar
• BaeJSParkSHJamiyandorjUCK2alpha/CSNK2A1 phosphorylates SIRT6 and is involved in the progression of breast carcinoma and predicts shorter survival of diagnosed patientsAm J Pathol2016186123297331527746184
   PubMed Web of Science ®Google Scholar
• OhCParkSLeeEKYooYJDownregulation of ubiquitin level via knockdown of polyubiquitin gene Ubb as potential cancer therapeutic interventionSci Rep20133262324022007
   PubMed Web of Science ®Google Scholar
• WeygantNQuDBerryWLSmall molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1Mol Cancer20141310324885928
   PubMed Web of Science ®Google Scholar
• SourbierCRickettsCJMatsumotoSTargeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancerCancer Cell201426684085025490448
   PubMed Web of Science ®Google Scholar
• GohGSchollUIHealyJMRecurrent activating mutation in PRKACA in cortisol-producing adrenal tumorsNat Genet201446661361724747643
   PubMed Web of Science ®Google Scholar
• HaTKChiSGCAV1/caveolin 1 enhances aerobic glycolysis in colon cancer cells via activation of SLC2A3/GLUT3 transcriptionAutophagy20128111684168522874559
   PubMed Web of Science ®Google Scholar
• ShaulianEAP-1 – The Jun proteins: Oncogenes or tumor suppressors in disguise?Cell Signal201022689489920060892
   PubMed Web of Science ®Google Scholar
• Vander HeidenMGDeBerardinisRJUnderstanding the intersections between metabolism and cancer biologyCell2017168465766928187287
   PubMed Web of Science ®Google Scholar
• ManasanchEEOrlowskiRZProteasome inhibitors in cancer therapyNat Rev Clin Oncol201714741743328117417
   PubMed Web of Science ®Google Scholar
• OttoTSicinskiPCell cycle proteins as promising targets in cancer therapyNat Rev Cancer20171729311528127048
   PubMed Web of Science ®Google Scholar
• TangYCheungBBAtmadibrataBThe regulatory role of long noncoding RNAs in cancerCancer Lett2017391121928111137
   PubMed Web of Science ®Google Scholar
• JangMKohILeeSJCheongJHKimPDroplet-based microtumor model to assess cell–ECM interactions and drug resistance of gastric cancer cellsSci Rep201774154128128310
   PubMed Web of Science ®Google Scholar
• DeyNDePLeyland-JonesBPI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trialsPharmacol Ther20171759110628216025
   PubMed Web of Science ®Google Scholar
• SchmuklerEKloogYPinkas-KramarskiRRas and autophagy in cancer development and therapyOncotarget20145357758624583697
   PubMedGoogle Scholar
• BrozovichFVNicholsonCJDegenCVGaoYZAggarwalMMorganKGMechanisms of vascular smooth muscle contraction and the basis for pharmacologic treatment of smooth muscle disordersPharmacol Rev201668247653227037223
   PubMed Web of Science ®Google Scholar
• ZhanTRindtorffNBoutrosMWnt signaling in cancerOncogene201736111461147327617575
   PubMed Web of Science ®Google Scholar
• LiNXiYTinsleyHNSulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/beta-catenin signalingMol Cancer Ther20131291848185923804703
   PubMed Web of Science ®Google Scholar
• ChenZLiJLLinScAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growthJ Clin Invest201612662267227927140397
   PubMed Web of Science ®Google Scholar
• LoganCVSzabadkaiGSharpeJALoss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signalingNat Genet201446218819324336167
   PubMed Web of Science ®Google Scholar
• MacheretMHalazonetisTDDNA replication stress as a hallmark of cancerAnnu Rev Pathol20151042544825621662
   PubMed Web of Science ®Google Scholar
• BrighentiETrereDDerenziniMTargeted cancer therapy with ribosome biogenesis inhibitors: a real possibility?Oncotarget2015636386173862726415219
   PubMedGoogle Scholar
• RouetteATrofimovAHaberlDExpression of immunoproteasome genes is regulated by cell-intrinsic and -extrinsic factors in human cancersSci Rep201663401927659694
   PubMed Web of Science ®Google Scholar
• GatzaMLSilvaGOParkerJSFanCPerouCMAn integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancerNat Genet201446101051105925151356
   PubMed Web of Science ®Google Scholar